Timo Minssen

Timo Minssen


Timo Minssen is Professor of Law at the University of Copenhagen (UCPH), and the Founding Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL). He is also an LML Research Affiliate at the University of Cambridge (UK), and an Inter-CeBIL Research Affiliate, Petrie-Flom Centre for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School (US). His research, supervision, teaching & part-time advisory practice concentrates on Intellectual Property-, Competition & Regulatory Law, as well as on the law & ethics of emerging health & life science technologies, such as genome editing, big data, artificial intelligence and quantum technology. This involves a plethora of legal issues emerging during the lifecycle of relevant products and processes -  from the sustainable regulation of R&D and incentives for innovation to responsible technology transfer and commercialization. Based on both his academic and practical experience from law firms, courts & life science start-ups, Timo serves as a member of several international committees and as an advisor to the WHO, WIPO, EU Commission, various organizations, companies, national governments and law firms. He presents his research at international symposia, major law firms, the Universities of Oxford, Cambridge, Hong Kong & Tokyo,  Harvard Law School, Harvard Business School, Stanford Law School, Yale, MIT, the Broad institute, as well as at the  WHO, WIPO, European Medicines Agency and National Ehics Councils etc. His publications comprise 7 books, as well as 200+ articles and book chapters. Timo's research has been featured in i.a. The Economist, The Financial Times, El Mundo, Politico, WHO Bulletin, Times of India & Times Higher Education, and published in leading journals, such as Science, JAMA, NEJM Catalyst, Harvard Business Review, Harvard Business Manager, Nature Biotechnology, Nature Genetics, Nature Electronics, Nature PJ Digital Medicine, The Lancet Digital Health, PLoS-Computational Biology, Biotech. J., Drug Discovery, JLB, BLR, Person.Med., IIC, EIPR, ECLR, JIPLP, GRUR Int., Chi.-Kent J. Intell. Prop., IPQ, QMJIP, NIR & EUConst.LR. He is also a regular contributor on Harvard Law School's "Bill of Health" blog. 

Main research area

  • AI & Big Data in the Health & Life Sciences
  • Sustainable and responsible innovation & tech transfer
  • Pharmaceutical-, Life Science- & Biotech Law
  • Comparative European & US Patent Law
  • Intellectual Property Law & Open Innovation
  • EU Competition- & US Antitrust Law

Fields of interest

  • Law & ethics
  • Synthetic Biology & Nanotechnology
  • Law & (Emerging) Technologies, including AI and quantum tech
  • EU Law
  • Medical & Health Law
  • E-Health & Big Data


Past appointments

Research management

  1. Novo Nordisk Foundation's International Collaborative Bioscience Innovation & Law  (Inter-CeBIL) Programme (PI & grant recipient, 50 million DKK).
  2. CLASSICA: EU Horizon Project on AI-assisted surgery (coPI)
  3. AI@Care: Law and Ethics and Algorithmic Bias in Healthcare (Principal Investigator)
  4. KU Sustainability in Drug Development Network (grant co-recipient & steering committee member)
  5. SSHRC (Canadian Research Council) partnership grant:Global strategies to manage the global antimicrobial commons in a sustainable, acceptable, fair and effective (SAFE) manner (coPI , leader of CeBIL team)


  1. PI & grant recipient: Novo Nordisk Foundation's Collaborative Research Programme in Biomedical Innovation Law (2018-2023, grant size: ca. 5 mill EUR).
  2. The Quantum Law Project, Wallenberg (WASP-HS) Project at Lund University (coPI)
  3. Principal Investigator: Global genes, local concerns: Legal, ethical and scientific challenges in cross-national biobanking and translational exploitation,  (total grant size: ca. 3,6 mill EUR)
  4. coPI, steering committee member & WP leader: CoNEXT - Fertilizing the ground and harvesting the full potential of the new neutron and X-ray research infrastructures close to UCPH -  & steering committee member (total grant size: ca. 3,7 mill EUR)
  5. coPI, steering committeee member and WP leader: BioSYNergy - towards a Bio-Based Society (total grant: ca. 3,7 mill EUR)
  6. AdManI: Additive Manufacturing and Innovation: Technical, Economic, Legal, and Policy Related Aspects of Rising Technologies (International Research Partner)
  7. User Generated Law: Re-constructing Law in the Knowledge Society (coPI, WP leader)
  8. Co-supervisor for a PhD thesis and collaborator in an interdisciplinary research project on "Counterfeit Medicines" (in co-operation with the Faculty of Health and Medical Sciences).
  9. Co-supervisor for a PhD thesis and collaborator in an interdisciplinary research project on "Regulation of Biosimilars" (in co-operation with the Copenhagen Centre for Regulatory Sciences (CORS) and the Faculty of Health and Medical Sciences

Editorial tasks




  • IIC- International Review of Intellectual Property and Competition Law
  • Science
  • The Lancet
  • Journal of Law and the Biosciences 
  • European Pharmaceutical Law Review
  • QMJIP- Queen Mary Journal of Intellectual Property
  • PLOS Biology


PhD students

  • Mattias Karlsson Dinnetz, Patenting Personalised Medicine in Europe, In collaboration with Faculty of Law at KU Leuven (co-supervisor)
  • Leonard Floryan, Antimirobial Resistance and Pull Incentives (co-supervisor)


PostDocs related to past and ongoing research projects

  • Ana Nordberg (BioSYNergy)
  • Torsten Bjørn Larsen (CoNEXT)
  • Helen Yu (CoNEXT)
  • Jakob Wested (CeBIL)
  • Louise Druedahl (CeBIL & CLASSICA)
  • Christy Kollmar (CeBIL)
  • Behrang Kianzad (CeBIL)
  • Marcelo Corrales Compagnucci (CeBIL)
  • Audrey Lebret (Data+)


Teaching in courses for Professionals and PhD -students

Selected publications

  1. Published

    Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine

    Aboy, M., Crespo, C., Liddell, K., Minssen, Timo & Liddicoat, J., May 2019, In: Nature Biotechnology. 37, p. 513-518 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Knowledge transfer for large scale vaccine manufacturing

    Price II, W. N., Rai, A. & Minssen, Timo, 13 Aug 2020, In: Science. 369, 6506, p. 912-914

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development

    Minssen, Timo & Nordberg, A., 18 May 2020, Infectious Diseases in the New Millennium: Legal and Ethical Challenges. Eccleston-Turner, M. & Brassington, I. (eds.). Springer, p. 111-136 26 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  4. Published

    The problem with antibiotics

    Darrow, J. & Minssen, Timo, May 2019, In: The Economist. 431, 9144, p. 20 1 p.

    Research output: Contribution to journalLetterResearch

  5. Published

    Ethical and legal issues of ingestible electronic sensors

    Gerke, S., Minssen, Timo, Yu, H. & Cohen, G., 15 Aug 2019, In: Nature Electronics . 2, 8, p. 329–334 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Global Genes, Local Concerns: Legal, Ethical and Scientific Challenges in International Biobanking

    Minssen, Timo, Herrmann, Janne Rothmar & Schovsbo, Jens Hemmingsen, Apr 2019, Cheltenham: Edward Elgar Publishing. 304 p.

    Research output: Book/ReportBookResearch

  7. Published

    Shadow health records meet new data privacy laws

    Price II, W. N., Spector-Bagdady, K., Minssen, Timo & Kaminski, M., 1 Feb 2019, In: Science. 363, 6426, p. 448-450 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?

    Minssen, Timo, Kesselheim, A. & Darrow, J., 3 Jan 2019, In: Nature Biotechnology. 37, 1, p. 21-22 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

    Gerke, S., Stern, A. & Minssen, Timo, 10 Jul 2020, In: Nature PJ Digital Medicine. 3, p. 1-6 6 p., 94.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

    Aboy, M., Cohen, G., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S. & Minssen, Timo, 2 Oct 2019, In: Nature Biotechnology. 37, 10, p. 1118–1125 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    The European Artificial Intelligence Strategy: Implications and Challenges for Digital Health

    Cohen, G., Evgeniou, T., Gerke, S. & Minssen, Timo, 23 Jun 2020, In: The Lancet Digital Health. 2, 7, p. 376-379

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Regulatory responses to medical machine learning

    Minssen, Timo, Gerke, S., Aboy, M., Price II, W. N. & Cohen, G., Apr 2020, In: Journal of Law and the Biosciences . 7, 1, p. 1-18 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Selected activities

  1. Ethical Licensing for CRISPR: Exploring the Opportunities for Responsible Licensing Mechanisms to Restore Trust

    Van Zimmeren, E. (Speaker) & Minssen, Timo (Speaker)

    4 Mar 2019

    Activity: Talk or presentation typesLecture and oral contribution

  2. CTD Transparency and Commercial Confidentiality according to the CJEU’s Case Law (Basel)

    Minssen, Timo (Invited speaker)

    27 Feb 2019

    Activity: Talk or presentation typesLecture and oral contribution

  3. Scientific, Regulatory & Legal Dimensions of Recent Advances in Gene Editing

    Minssen, Timo (Organizer)

    4 Mar 2019

    Activity: Participating in an event - typesOrganisation of and participation in conference

  4. The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)

    Minssen, Timo (Invited speaker)

    8 Feb 2019

    Activity: Talk or presentation typesLecture and oral contribution

  5. Confessions of a party crasher: Artificial Intelligence and the Law(yer)

    Minssen, Timo (Invited speaker)

    31 Jan 2019

    Activity: Talk or presentation typesLecture and oral contribution

  6. Rättsliga aspekter av AI inom health och life sciences (Legal aspects of AI in the Health & Life Sciences)

    Minssen, Timo (Invited speaker)

    28 Jan 2019

    Activity: Talk or presentation typesLecture and oral contribution

Selected prizes

  1. King Oscar award for best Jur. Dr. thesis

    Minssen, Timo (Recipient), Apr 2014

    Prize: Prizes, scholarships, distinctions

  2. Jorcks Fonds Forsknings Pris (Jorck's Foundation Research Prize)

    Minssen, Timo (Recipient), 2017

    Prize: Prizes, scholarships, distinctions

  3. Awapatent Research Prize

    Minssen, Timo (Recipient), 2009

    Prize: Prizes, scholarships, distinctions

ID: 16150437